References
- Satoh J, Shintani S, Oya K et al. Treatment with streptococcal preparation (OK-432) suppresses anti-islet autoimmunity and prevents diabetes in BB rats. Diabetes 37(9), 1188–1194 (1988).
- Qin HY, Singh B. BCG vaccination prevents insulin-dependent diabetes mellitus (IDDM) in NOD mice after disease acceleration with cyclophosphamide. J. Autoimmun. 10(3), 271–278 (1997).
- Alyanakian MA, Grela F, Aumeunier A et al. Transforming growth factor-β and natural killer T-cells are involved in the protective effect of a bacterial extract on Type 1 diabetes. Diabetes 55(1), 179–185 (2006).
- King C, Sarvetnick N. The incidence of Type-1 diabetes in NOD mice is modulated by restricted flora not germ-free conditions. PLoS ONE 6(2), e17049 (2011).
- Brugman S, Klatter FA, Visser JT et al. Antibiotic treatment partially protects against Type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of Type 1 diabetes? Diabetologia 49(9), 2105–2108 (2006).
- Valladares R, Sankar D, Li N et al. Lactobacillus johnsonii N6.2 mitigates the development of Type 1 diabetes in BB-DP rats. PLoS ONE 5(5), e10507 (2010).
- Lee AS, Gibson DL, Zhang Y, Sham HP, Vallance BA, Dutz JP. Gut barrier disruption by an enteric bacterial pathogen accelerates insulitis in NOD mice. Diabetologia 53(4), 741–748 (2010).
- Lau K, Benitez P, Ardissone A et al. Inhibition of type 1 diabetes correlated to a Lactobacillus johnsonii N6.2-mediated Th17 bias. J. Immunol. 186(6), 3538–3546 (2011).
- Hansen AK, Ling F, Kaas A, Funda DP, Farlov H, Buschard K. Diabetes preventive gluten-free diet decreases the number of caecal bacteria in non-obese diabetic mice. Diabetes Metab. Res. Rev. 22(3), 220–225 (2006).
- Calcinaro F, Dionisi S, Marinaro M et al. Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse. Diabetologia 48(8), 1565–1575 (2005).
- Stene LC, Barriga K, Norris JM et al. Symptoms of common maternal infections in pregnancy and risk of islet autoimmunity in early childhood. Diabetes Care 26(11), 3136–3141 (2003).
- Infections and vaccinations as risk factors for childhood Type I (insulin-dependent) diabetes mellitus: a multicentre case–control investigation. EURODIAB Substudy 2 Study Group. Diabetologia 43(1), 47–53 (2000).
- Abela AG, Fava S. Association of incidence of Type 1 diabetes with mortality from infectious disease and with antibiotic susceptibility at a country level. Acta Diabetol. (2013).
- Giongo A, Gano KA, Crabb DB et al. Toward defining the autoimmune microbiome for Type 1 diabetes. ISME J. 5(1), 82–91 (2011).
- Brown CT, Davis-Richardson AG, Giongo A et al. Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for Type 1 diabetes. PLoS ONE 6(10), e25792 (2011).
- Sadauskaite-Kuehne V, Ludvigsson J, Padaiga Z, Jasinskiene E, Samuelsson U. Longer breastfeeding is an independent protective factor against development of Type 1 diabetes mellitus in childhood. Diabetes Metab. Res. Rev. 20(2), 150–157 (2004).
- Donnet-Hughes A, Perez PF, Doré J et al. Potential role of the intestinal microbiota of the mother in neonatal immune education. Proc. Nutr. Soc. 69(3), 407–415 (2010).
- Cardwell CR, Stene LC, Joner G et al. Caesarean section is associated with an increased risk of childhood-onset Type 1 diabetes mellitus: a meta-analysis of observational studies. Diabetologia 51(5), 726–735 (2008).
- Dominguez-Bello MG, Costello EK, Contreras M et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc. Natl Acad. Sci.107(26), 11971–11975 (2010).
- Cardwell CR, Carson DJ, Patterson CC. No association between routinely recorded infections in early life and subsequent risk of childhood-onset Type 1 diabetes: a matched case–control study using the UK General Practice Research Database. Diabet. Med. 25(3), 261–267 (2008).